Galantamine
AISCBF2025
Phase 3 small_molecule active
Quick answer
Galantamine for Acute Ischemic Stroke AIS is a Phase 3 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Acute Ischemic Stroke AIS
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active